i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Sore throat following three adult supraglottic airway devices

L'Hermite J, Dubout E, Bouvet S, Bracoud LH, Cuvillon P, Coussaye JE, Ripart J. Eur J Anaesthesiol. 2017 Jul;34(7):417-424

Comparison of the incidence of sore throat in 546 patients following use of LMA Unique, LMA Supreme and the i-gel. Primary outcome was incidence 24 hours postoperatively. Authors concluded that recordings were not significantly different between the three devices.

Link to abstract

A comparison of various supraglottic airway devices for fiberoptical guided tracheal intubation

Metterlein T, Dintenfelder A, Plank C, Graf B, Roth G. Rev Bras Anestesiol. 2017 Mar - Apr;67(2):166-171

Random assignment of 52 adult patients to different supraglottic devices, from: Laryngeal Tube, LMA, i-gel, LMA Unique, LMA Supreme and Aura-once. After successful ventilation, device positioning was examined to assess glottic opening. Glottic view ranged from 40% for Laryngeal Tube to 90%, with i-gel recording 70%.

Link to abstract.

Comparison of the i-gel and other supraglottic airways in adult manikin studies: systematic review and meta-analysis

An J, Nam SB, Lee JS, Lee J, Yoo H, Lee HM, Kim MS. Medicine (Baltimore). 2017 Jan;96(1):e5801

Authors conducted a specialised search of study databases for eligible randomised controlled trials, setting device insertion time and first-attempt insertion success rate as their primary outcomes. In the 14 RCTs included, i-gel was faster than the majority of other supraglottic airways, with only three others recording shorter insertion times. Authors concluded that the 'unapparent advantage' of insertion success rate indicated the need for further evidence gathering in this area.

Link to abstract.

About laryngeal mask: is the lowest price material the better cost-efficacy choice?

Weil G, Matysiak J, Guye ML, Eghiaian A, Bourgain JL. Ann Fr Anesth Reanim. 2014 Sep-Oct;33(9-10):508-13

Using LMA Unique as a reference, cost efficacy comparisons were made against i-gel, Ambu AuraOnce and LMA Supreme. Conclusions suggested that latest generation devices are still expensive despite low rate of complications.

Link to abstract

Randomised crossover comparison between the i-gel® and the LMA Unique® in anaesthetised, paralysed adults

Uppal V, Gangaiah S, Fletcher G, Kinsella J. Br J Anaesth 2009; 103(6): 882-885

In this study, the i-gel® and LMA Unique® were both used in 39 patients. Leak pressure, insertion attempts, number of airway manipulations and leak volumes were similar for both devices. Insertion time was significantly less for the i-gel® at 12.2s compared to 15.2s for the LMA Unique®. It can be concluded that the i-gel® is a reasonable alternative to the LMA Unique® during controlled ventilation.

Link to abstract.